Joost Schepers
Papers
1
Total Citations
14
H-Index
1
About
Joost Schepers is a virologist whose work sits at the critical intersection of antiviral drug discovery and high-throughput screening technologies. His most impactful contribution to date is the development of a robust, dual-reporter high-throughput screening assay for SARS-CoV-2, a tool designed to accelerate the search for effective antiviral compounds during the pandemic. This fully automated assay, which has already garnered 14 citations, represents a significant methodological advance, enabling researchers to rapidly and reliably test thousands of potential drug candidates against the live virus. By streamlining the path from compound library to hit identification, Schepers’ work directly supported the global effort to move beyond vaccines and secure therapeutic options for COVID-19. His research exemplifies how clever assay design can bridge the gap between basic virology and practical, scalable drug discovery, making him a key contributor to the infrastructure of pandemic preparedness and antiviral development.
Research Focus
Key Achievements
Top Papers
- 1